ArticleCureus2026
Functional Neurological Symptom Disorder Obscured by Incomplete Diagnostic Communication: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Functional neurological disorder (FND) is a diagnosis grounded in positive clinical signs, yet it remains vulnerable to underdocumentation and incomplete communication across care transitions, particularly when it is suspected but not formally recorded. In this case, a 24-year-old woman with a history of major trauma (three gunshot wounds sustained four years earlier) presented with sudden-onset left lower extremity (LLE) weakness, pain, and tingling coinciding with the anniversary month of her injury. Extensive neuroimaging and serologic workup were unrevealing aside from an incidental disc protrusion and elevated angiotensin-converting enzyme (ACE) titers. Due to the presence of localized lower extremity plegia and anesthesia in the absence of structural pathology on neuroimaging, the patient was empirically treated for suspected autoimmune plexopathy with high-dose methylprednisolone, intravenous immunoglobulin (IVIG), and plasmapheresis without sustained benefit. On transfer to a tertiary center, examination revealed fluctuating strength and non-anatomic sensory loss; electromyography was inconclusive. The patient was discharged with a diagnosis of "suspected plexopathy of the lumbosacral plexus," though peer-to-peer consultation later revealed that the tertiary team's leading differential had, in fact, been FND, a suspicion that was never formally documented. On admission to acute inpatient rehabilitation, neuropsychological evaluation suggested a history of post-traumatic stress disorder (PTSD) and a positive Hoover's sign supporting functional weakness. A diagnosis of FND was established, taking into account the entire clinical assessment, including history, physical examination, and multidisciplinary evaluation. This case demonstrates that a functional diagnosis privately suspected but not formally documented can be effectively lost at a transition of care, exposing the patient to repeated invasive empiric therapy and diagnostic delay. Formally documenting FND as an active differential diagnosis and delivering an early, transparent, biopsychosocially framed explanation to the patient may reduce iatrogenic harm and support engagement in rehabilitation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.